|| AstraZeneca vaccine 79% effective against symptomatic Covid ||The company announced the findings from the new Phase 3 trial, which included more than 32,000 participants and may boost confidence in the vaccine
|| AstraZeneca vaccine 79% effective against symptomatic Covid ||The company announced the findings from the new Phase 3 trial, which included more than 32,000 participants and may boost confidence in the vaccine